■ 영문 제목 : Global Emerging Cancer Diagnostics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024 | |
![]() | ■ 상품코드 : GIR-AB0810 ■ 조사/발행회사 : Globalinforesearch ■ 발행일 : 2019년 1월 23일 ■ 페이지수 : 116 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
Single User (1명 열람용) | USD3,480 ⇒환산₩3,828,000 | 견적의뢰/주문/질문 |
Multi User (5명 열람용) | USD5,220 ⇒환산₩5,742,000 | 견적의뢰/주문/질문 |
Corporate User (동일기업내 공유가능) | USD6,960 ⇒환산₩7,656,000 | 견적의뢰/구입/질문 |
※가격옵션 설명 - 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다. - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다. |
본 조사보고서는 신규 암진단의 세계시장에 대해서 조사분석한 자료로서, 신규 암진단의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 신규 암진단시장동향 ・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율) ・주요 지역별 신규 암진단 시장분석/시장규모 - 북미시장 (미국, 캐나다, 멕시코) - 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아) - 아시아시장 (중국, 일본, 한국, 인도, 동남아시아) - 남미시장 (브라질, 아르헨티나, 콜롬비아) - 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카) ・신규 암진단의 종류별 시장분석/시장규모 ・신규 암진단의 용도별 시장분석/시장규모 ・신규 암진단의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측) ・신규 암진단의 판매채널, 유통업체 분석 ... |
Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation.
Scope of the Report:
The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Emerging Cancer Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Emerging Cancer Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Emerging Cancer Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Danaher
Agilent Technologies
AstraZeneca
BD
Biocept
Illumina
Luminex
NeoGenomics
QIAGEN
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Men
Women
Market Segment by Applications, can be divided into
Blood Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Others
Table of Contents 1 Emerging Cancer Diagnostics Market Overview Figure Emerging Cancer Diagnostics Picture Table Product Specifications of Emerging Cancer Diagnostics Table Global Emerging Cancer Diagnostics and Revenue (Million USD) Market Split by Product Type Figure Global Emerging Cancer Diagnostics Revenue Market Share by Types in 2018 Figure Men Picture Figure Women Picture Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Application (2014-2024) Figure Emerging Cancer Diagnostics Revenue Market Share by Applications in 2018 Figure Blood Cancer Picture Figure Prostate Cancer Picture Figure Breast Cancer Picture Figure Lung Cancer Picture Figure Others Picture Table Global Market Emerging Cancer Diagnostics Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Emerging Cancer Diagnostics Type and Applications Table Abbott Laboratories Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Danaher Basic Information, Manufacturing Base and Competitors Table Danaher Emerging Cancer Diagnostics Type and Applications Table Danaher Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Agilent Technologies Basic Information, Manufacturing Base and Competitors Table Agilent Technologies Emerging Cancer Diagnostics Type and Applications Table Agilent Technologies Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Emerging Cancer Diagnostics Type and Applications Table AstraZeneca Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table BD Basic Information, Manufacturing Base and Competitors Table BD Emerging Cancer Diagnostics Type and Applications Table BD Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Biocept Basic Information, Manufacturing Base and Competitors Table Biocept Emerging Cancer Diagnostics Type and Applications Table Biocept Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Illumina Basic Information, Manufacturing Base and Competitors Table Illumina Emerging Cancer Diagnostics Type and Applications Table Illumina Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Luminex Basic Information, Manufacturing Base and Competitors Table Luminex Emerging Cancer Diagnostics Type and Applications Table Luminex Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table NeoGenomics Basic Information, Manufacturing Base and Competitors Table NeoGenomics Emerging Cancer Diagnostics Type and Applications Table NeoGenomics Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table QIAGEN Basic Information, Manufacturing Base and Competitors Table QIAGEN Emerging Cancer Diagnostics Type and Applications Table QIAGEN Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors Table Thermo Fisher Scientific Emerging Cancer Diagnostics Type and Applications Table Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Players (2014-2019) Table Global Emerging Cancer Diagnostics Revenue Share by Players (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Share by Players in 2017 Figure Global Emerging Cancer Diagnostics Revenue Share by Players in 2018 Figure Global Top 5 Players Emerging Cancer Diagnostics Revenue Market Share in 2018 Figure Global Top 10 Players Emerging Cancer Diagnostics Revenue Market Share in 2018 Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Regions (2014-2019) Table Global Emerging Cancer Diagnostics Revenue Market Share by Regions (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Market Share by Regions (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Market Share by Regions in 2018 Figure North America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Europe Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure South America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table North America Emerging Cancer Diagnostics Revenue by Countries (2014-2019) Table North America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure North America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure North America Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018 Figure USA Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Canada Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Mexico Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table Europe Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019) Figure Europe Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure Europe Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018 Figure Germany Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure UK Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure France Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Russia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Italy Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table Asia-Pacific Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018 Figure China Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Japan Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Korea Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure India Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Southeast Asia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table South America Emerging Cancer Diagnostics Revenue by Countries (2014-2019) Table South America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure South America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure South America Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018 Figure Brazil Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Argentina Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Colombia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table Middle East and Africa Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018 Figure Saudi Arabia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure UAE Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Egypt Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure Nigeria Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Figure South Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019) Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Type (2014-2019) Table Global Emerging Cancer Diagnostics Revenue Share by Type (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Share by Type (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Share by Type in 2019 Table Global Emerging Cancer Diagnostics Revenue Forecast by Type (2019-2024) Figure Global Emerging Cancer Diagnostics Market Share Forecast by Type (2019-2024) Figure Global Men Revenue Growth Rate (2014-2019) Figure Global Women Revenue Growth Rate (2014-2019) Table Global Emerging Cancer Diagnostics Revenue by Application (2014-2019) Table Global Emerging Cancer Diagnostics Revenue Share by Application (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Share by Application (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue Share by Application in 2019 Table Global Emerging Cancer Diagnostics Revenue Forecast by Application (2019-2024) Figure Global Emerging Cancer Diagnostics Market Share Forecast by Application (2019-2024) Figure Global Blood Cancer Revenue Growth Rate (2014-2019) Figure Global Prostate Cancer Revenue Growth Rate (2014-2019) Figure Global Breast Cancer Revenue Growth Rate (2014-2019) Figure Global Lung Cancer Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Emerging Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Emerging Cancer Diagnostics Revenue Market Share Forecast by Regions (2019-2024) Figure North America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024) Figure Europe Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024) Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024) Figure South America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024) Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024) |
※본 조사보고서 [세계의 신규 암진단 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] (코드 : GIR-AB0810) 판매에 관한 면책사항을 반드시 확인하세요. |
※본 조사보고서 [세계의 신규 암진단 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요. |